• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2'-甲酰胺核苷亚磷酰胺的合成及其对 siRNA 基于种子的脱靶效应的抑制作用。

Synthesis of 2'-formamidonucleoside phosphoramidites for suppressing the seed-based off-target effects of siRNAs.

机构信息

Department of Chemistry, Graduate School of Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan.

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.

出版信息

Nucleic Acids Res. 2024 Oct 14;52(18):10754-10774. doi: 10.1093/nar/gkae741.

DOI:10.1093/nar/gkae741
PMID:39231537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11472056/
Abstract

In this study, we report the synthesis of 2'-formamidonucleoside phosphoramidite derivatives and their incorporation into siRNA strands to reduce seed-based off-target effects of small interfering RNAs (siRNAs). Formamido derivatives of all four nucleosides (A, G, C and U) were synthesized in 5-11 steps from commercial compounds. Introducing these derivatives into double-stranded RNA slightly reduced its thermodynamic stability, but X-ray crystallography and CD spectrum analysis confirmed that the RNA maintained its natural A-form structure. Although the introduction of the 2'-formamidonucleoside derivative at the 2nd position in the guide strand of the siRNA led to a slight decrease in the on-target RNAi activity, the siRNAs with different sequences incorporating 2'-formamidonucleoside with four kinds of nucleobases into any position other than 2nd position in the seed region revealed a significant suppression of off-target activity while maintaining on-target RNAi activity. This indicates that 2'-formamidonucleosides represent a promising approach for mitigating off-target effects in siRNA therapeutics.

摘要

在这项研究中,我们报告了 2'-甲酰胺核苷亚磷酰胺衍生物的合成及其在 siRNA 链中的掺入,以降低小干扰 RNA(siRNA)的基于种子的脱靶效应。所有四种核苷(A、G、C 和 U)的甲酰胺衍生物均由商业化合物经 5-11 步合成得到。将这些衍生物引入双链 RNA 中会略微降低其热力学稳定性,但 X 射线晶体学和 CD 光谱分析证实 RNA 保持其天然的 A 型结构。尽管在 siRNA 向导链的第 2 位引入 2'-甲酰胺核苷衍生物会导致针对靶 RNAi 活性略有下降,但在种子区域的第 2 位以外的任何位置引入带有四种碱基的 2'-甲酰胺核苷的不同序列的 siRNA 会显著抑制脱靶活性,同时保持针对靶 RNAi 活性。这表明 2'-甲酰胺核苷代表了一种有前途的方法,可以减轻 siRNA 治疗中的脱靶效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/110425e6c339/gkae741fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/627314b9a107/gkae741figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/0ebf33438aba/gkae741fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/6652eed1ac18/gkae741_sch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/4b20fb6d851e/gkae741fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/8a739683c77a/gkae741fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/cb0a69e966a4/gkae741fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/d173470a08a8/gkae741fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/110425e6c339/gkae741fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/627314b9a107/gkae741figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/0ebf33438aba/gkae741fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/6652eed1ac18/gkae741_sch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/4b20fb6d851e/gkae741fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/8a739683c77a/gkae741fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/cb0a69e966a4/gkae741fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/d173470a08a8/gkae741fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81b0/11472056/110425e6c339/gkae741fig6.jpg

相似文献

1
Synthesis of 2'-formamidonucleoside phosphoramidites for suppressing the seed-based off-target effects of siRNAs.2'-甲酰胺核苷亚磷酰胺的合成及其对 siRNA 基于种子的脱靶效应的抑制作用。
Nucleic Acids Res. 2024 Oct 14;52(18):10754-10774. doi: 10.1093/nar/gkae741.
2
Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.酰胺修饰 RNA:利用蛋白质骨架调节短干扰 RNA 的功能。
Acc Chem Res. 2020 Sep 15;53(9):1782-1790. doi: 10.1021/acs.accounts.0c00249. Epub 2020 Jul 13.
3
Building siRNAs with Cubes: Synthesis and Evaluation of Cubane-Modified siRNAs.用立方烷构建小干扰RNA:立方烷修饰的小干扰RNA的合成与评估
Chembiochem. 2021 Oct 13;22(20):2981-2985. doi: 10.1002/cbic.202100334. Epub 2021 Aug 11.
4
Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.2'-O-胍基丙基修饰核苷亚磷酰胺的合成及其在靶向乙型肝炎病毒的 siRNAs 中的应用。
Bioorg Med Chem. 2012 Feb 15;20(4):1594-606. doi: 10.1016/j.bmc.2011.12.024. Epub 2011 Dec 21.
5
Synthesis and Biological Activity of Short Interfering RNAs Having Several Consecutive Amide Internucleoside Linkages.具有几个连续酰胺核苷内键的短干扰 RNA 的合成与生物活性。
Chemistry. 2020 Jan 13;26(3):685-690. doi: 10.1002/chem.201903754. Epub 2019 Dec 17.
6
Properties of short double-stranded RNAs carrying randomized base pairs: toward better controls for RNAi experiments.携带随机碱基对的短双链RNA的特性:用于更好地控制RNA干扰实验
RNA. 2015 Dec;21(12):2132-42. doi: 10.1261/rna.053637.115. Epub 2015 Oct 29.
7
siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.siDirect 2.0:一款用于设计具有降低的种子依赖性脱靶效应的功能性 siRNA 的软件更新。
BMC Bioinformatics. 2009 Nov 30;10:392. doi: 10.1186/1471-2105-10-392.
8
A computational study of off-target effects of RNA interference.RNA干扰脱靶效应的计算研究。
Nucleic Acids Res. 2005 Mar 30;33(6):1834-47. doi: 10.1093/nar/gki324. Print 2005.
9
Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs.使用异核苷酸克服 GNA/RNA 碱基配对限制可提高 ESC+GalNAc-siRNAs 的药效活性。
Nucleic Acids Res. 2021 Nov 8;49(19):10851-10867. doi: 10.1093/nar/gkab916.
10
Synthesis and properties of 4'-C-aminoalkyl-2'-fluoro-modified RNA oligomers.4′-C-氨烷基-2′-氟修饰的 RNA 寡聚物的合成与性质。
Bioorg Med Chem. 2018 Aug 15;26(15):4574-4582. doi: 10.1016/j.bmc.2018.08.001. Epub 2018 Aug 2.

引用本文的文献

1
Single alkyl phosphonate modification of the siRNA backbone in the seed region enhances specificity and therapeutic profile.种子区域中siRNA骨架的单烷基膦酸酯修饰可提高特异性和治疗效果。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf692.
2
The XNA alphabet.XNA字母表。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf635.

本文引用的文献

1
Amide Modifications in the Seed Region of the Guide Strand Improve the On-Target Specificity of Short Interfering RNA.引导链种子区的酰胺修饰可提高短干扰 RNA 的靶标特异性。
ACS Chem Biol. 2023 Jan 20;18(1):7-11. doi: 10.1021/acschembio.2c00769. Epub 2022 Dec 29.
2
Vutrisiran: First Approval.维特利西单抗:首次获批。
Drugs. 2022 Sep;82(13):1419-1425. doi: 10.1007/s40265-022-01765-5. Epub 2022 Aug 23.
3
A 2'-modified uridine analog, 2'-O-(methylthiomethoxy)methyl uridine, for siRNA applications.一种 2'-修饰的尿嘧啶类似物,2'-O-(甲硫基甲氧基)甲基尿苷,用于 siRNA 应用。
Bioorg Med Chem Lett. 2022 Oct 15;74:128939. doi: 10.1016/j.bmcl.2022.128939. Epub 2022 Aug 12.
4
From bench to bedside: Improving the clinical safety of GalNAc-siRNA conjugates using seed-pairing destabilization.从实验室到临床:通过种子配对失稳提高 GalNAc-siRNA 缀合物的临床安全性。
Nucleic Acids Res. 2022 Jul 8;50(12):6656-6670. doi: 10.1093/nar/gkac539.
5
Inclisiran: First Approval.依洛尤单抗:首次获批
Drugs. 2021 Feb;81(3):389-395. doi: 10.1007/s40265-021-01473-6.
6
Lumasiran: First Approval.鲁马西单抗:首次获批。
Drugs. 2021 Feb;81(2):277-282. doi: 10.1007/s40265-020-01463-0.
7
Givosiran: First Approval.吉伏昔兰:首次获批
Drugs. 2020 Feb;80(3):335-339. doi: 10.1007/s40265-020-01269-0.
8
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.基于图的基因组比对和基因分型与 HISAT2 和 HISAT-genotype。
Nat Biotechnol. 2019 Aug;37(8):907-915. doi: 10.1038/s41587-019-0201-4. Epub 2019 Aug 2.
9
Patisiran: First Global Approval.帕替沙那:全球首次获批。
Drugs. 2018 Oct;78(15):1625-1631. doi: 10.1007/s40265-018-0983-6.
10
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity.筛选具有有限脱靶驱动大鼠肝毒性的GalNAc缀合小干扰RNA。
Nat Commun. 2018 Feb 19;9(1):723. doi: 10.1038/s41467-018-02989-4.